°®¶ûÀ¼¶¼°ØÁÖÊ¥ÈýһѧԺÕÐƸÉúÎï»ù¾ÛºÏÎïÑо¿²©Ê¿ºóְλ

Post Title: Postdoctoral position ¨C Bio based polymers
Post Status: 1 year contract; Available immediately
Department/Faculty: Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN)
Location: Main Campus
Salary: € 37,750 ¨C € 40,003
Closing Date: 06 September 2013

An experienced researcher is required for an Industry driven project in bio based and bio degradable polymer composites. The project involves the development of biodegradable polymer blends/composites based on commercially available biopolymers with applications in the biomedical sector. This role will involve working with an interdisciplinary research group.

The successful candidate must have a PhD with a suitable background in polymer nanocomposites, characterisation, medical device polymers, biodegradable polymers, polymer processing and compounding. The candidates must have a strong desire and motivation to conduct independent and innovative research, and must have excellent oral and written communication skills.

The individual must be a self-determined individual with a capacity to apply new, pre-existing or adjacent technologies to problem solving with minimal supervision. They must also have excellent communication and written skills. A good leadership skill with the ability to maintain excellent working relationships with both internal and external customers is also required.

Apply:
Candidates interested in the role can contact Dr.Ramesh Babu on +353 1 896 2602 or babup@tcd.ie for more information. All applicants should send their CV to Dr Babu at babup@tcd.ie

CRANN Overview
The Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN) comprises a team of over two hundred and fifty researchers from 45 different countries, led by eighteen principal investigators and seventeen investigators, each of whom is an internationally recognised expert in his/her field of research.CRANN principal investigators are based across multiple disciplines including physics, chemistry, medicine, biochemistry and immunology, engineering and pharmacy. CRANN works at the frontiers of nanoscience developing new knowledge of nanoscale chemical and physical phenomena, with a particular focus on new device and sensor technologies for ICT, biotechnology and medical sectors.
CRANN has two state-of-the art buildings both custom designed and constructed for the purpose of leading edge nanoscience research. The Naughton Institute is a 6000m2 research facility on the campus of TCD. The CRANN Advanced Microscopy Laboratory (AML) was completed in 2009. This facility is on Pearse Street and houses Ireland¡¯s most advanced microscopy instrumentation, enabling Ireland to compete internationally in terms of this capability. The impact is being measured in terms of Ireland 8th place ranking in materials science, of which over 70% of the cited publications are linked to CRANN and its partner schools.
Through its SFI funded Centre for Science, Engineering and Technology (CSET), CRANN has a specific remit to work with industry. CRANN presently has active research engagement with over seventy companies in Ireland and Europe, including multinationals such as Intel and HP and indigenous companies such as Cellix and Eblana Photonics. CRANN has also been very successful in obtaining non-Exchequer funding (e.g. European Union Frameworks) that enabled the establishment of an extensive academic partnership network involving over 100 European universities and 160 universities globally.
On a national basis CRANN leads the INSPIRE consortium (www.inspirenano.com) which comprises the foremost nanoscience researchers in Ireland based across eight academic institutions. CRANN, in partnership with the Tyndall National Institute, will co-host the Competence Centre for Applied Nanotechnology. This is a new initiative to enable research provider organisations to partner one another on an industry defined research programme.
CRANN has been funded predominately by Science Foundation Ireland and has also obtained competitive funding from the Higher Education Authority, Enterprise Ireland, industry, the EU commission through FP6 and FP7 and philanthropic sources, notably Dr Martin Naughton.